Viking Therapeutics (VKTX) Misses Q2 EPS by 1c
Viking Therapeutics (NASDAQ: VKTX) reported Q2 EPS of ($0.21), $0.01 worse than the analyst estimate of ($0.20).
For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.
Viking Therapeutics (NASDAQ: VKTX) reported Q2 EPS of ($0.21), $0.01 worse than the analyst estimate of ($0.20).
For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.